Quantification of sequencing instruments and reagents for use in molecular diagnostic methods
A system qualifies and monitors sequencing instruments and reagents to ensure compliance with quality standards, preventing unqualified reports and ensuring accurate diagnostic results.
Patent Information
- Application Number
- JP2024153853
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-05-09
- Filing Date
- 2024-09-06
- Publication Date
- 2024-11-28
- Estimated Expiration
- 2040-01-06
AI Technical Summary
The quality of sequencing equipment and reagents used in molecular diagnostics varies, leading to inconsistencies in diagnostic accuracy, necessitating a system to qualify and monitor these components to ensure compliance with quality standards.
A system and method for qualifying sequencing instruments and reagents, including a processor that determines the status of equipment and reagents based on approved software, qualification runs, and expiration dates, and prevents access to diagnostic reports if not qualified, while allowing access to research reports.
Ensures the generation of accurate diagnostic reports by ensuring only qualified equipment and reagents are used, thereby maintaining diagnostic integrity and preventing the release of unqualified reports.
Smart Images

Figure 2024166269000001_ABST
Abstract
Description
[Technical field]
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit of priority under 35 U.S.C. §119(e) to U.S. patent application Ser. No. 62 / 789,421, filed January 7, 2019, and U.S. patent application Ser. No. 62 / 845,564, filed May 9, 2019, the disclosures of both applications being incorporated by reference in their entireties in their entireties herein.
[0002] Field of the Disclosure The present disclosure relates to genetic analysis, and more particularly to systems, methods, and programs that qualify, check, and monitor the use of diagnostic equipment and reagents, such as sequencing equipment and reagents, to ensure the performance and quality of diagnostic methods. [Background technology]
[0003] Background information Clinical diagnostic testing is becoming increasingly essential in healthcare. Particularly in the field of in vitro diagnostics (IVD), breakthroughs in molecular diagnostics are opening up entirely new opportunities for diagnostics to drive medical decision-making and care.
[0004] IVD refers to disease testing that is performed on samples removed from the body for analysis. There are a myriad of technologies currently used to test for disease, analyzing a wide variety of biomarkers such as proteins, genes, enzymes, and other analytes that are indicative of disease.
[0005] Most diagnostic tests are performed in a laboratory setting using diagnostic techniques, some of which include immunoassays, molecular diagnostics, clinical chemistry, mass spectrometry, proteomics, microbiome analysis, microbiology, hematology, etc., to name a few.
[0006] Certain types of molecular diagnostic techniques involve the use of sequencing instruments that perform assay runs on DNA using one or more reagents. The report containing the results of the sequencing run may be analyzed using an analysis plan created by the user. This analysis may be used for multiple diagnoses. However, the quality of sequencing instruments varies from instrument to instrument and may tend to deteriorate over time. Additionally, reagents may vary from lot to lot.
[0007] This phenomenon is present in the equipment used for almost all diagnostic techniques. Thus, a need exists to ensure that the equipment used to generate the diagnostic report meets the quality standards required for IVDs to ensure diagnostic accuracy. Summary of the Invention
[0008] Thus, systems and methods are disclosed that perform qualification of diagnostic devices and / or reagents used by the diagnostic devices and prevent access to at least diagnostic analysis reports generated as a result of analysis of reports obtained from non-qualified diagnostic devices and / or using non-qualified reagents, as well as programs therefor.
[0009] In one aspect, the present disclosure provides systems and methods for performing qualification of sequencing instruments and / or reagents used by the sequencing instruments and preventing access to at least diagnostic analysis reports generated as a result of analysis of reports obtained from non-qualified sequencing instruments and / or using non-qualified reagents. Other reports, such as complete run reports, generated from sequencing run reports obtained from the sequencing instruments may also be retained. Programs therefor are also disclosed.
[0010] In one aspect of the disclosure, a system includes a memory, a network interface, and a processor. The memory is configured to store a sequencing instrument identifier and associated status, a reagent identifier and associated status, and an approved software identifier. The status may include qualified or unqualified. The status for the reagent may also be expired. The status for the sequencing instrument may also be expired qualification. Both the reagent and the sequencing instrument may have a status of not being tested.
[0011] The network interface is configured to communicate with the sequencing device and the client terminal.
[0012] The processor is configured to receive a report from the sequencing instrument through the network interface about the sequencing run and determine whether the sequencing run has been designated as a qualification run.
[0013] The report may include an identifier for the sequencing instrument that generated the report, identifiers for the reagents used in the sequencing run, identifiers for the software installed on the sequencing instrument, and the results of the sequencing run.
[0014] If the sequencing run is determined to be designated as a qualification run, the processor is further configured to determine whether the software installed on the sequencing instrument is approved software, examine the results of the sequencing run to determine whether the sequencing instrument or reagents are qualified, and, in response to the examination, update an associated status for at least one of the sequencing instrument and the reagents. If the software installed on the sequencing instrument is not approved, the associated status of the sequencing instrument is not qualified.
[0015] In one aspect of the present disclosure, a sequencing run may be designated as a qualification run to perform qualification of the sequencing instrument only, reagents only, or both the sequencing instrument and reagents.
[0016] The processor is further configured to determine whether the analysis requested for the sequencing run is in a diagnostic mode. If the analysis is determined to be in a diagnostic mode, the processor is further configured to determine whether software installed on the sequencing instrument is approved software, determine whether the sequencing instrument is qualified, and determine whether reagents used in the sequencing run are qualified.
[0017] If the software installed on the sequencing instrument is not approved or if the sequencing instrument and / or reagents are not qualified, the processor is configured to retain a diagnostic analysis report generated from the report in the memory. The processor may also retain a complete run report generated for the sequencing run.
[0018] In one aspect of the present disclosure, the processor is configured to disable generation of the analysis plan in diagnostic mode if at least one of the sequencing instrument and the reagents have not been qualified (or tested).
[0019] In one aspect of the present disclosure, the processor is configured to allow access to the diagnostic analysis report by the client terminal if the software installed on the sequencing device is approved and both the sequencing device and reagents have been qualified.
[0020] In one aspect of the disclosure, the processor is further configured to change the status of the reagent to disqualified if the current date is after the expiration date of the reagent.
[0021] In one aspect of the disclosure, the processor is configured to change the status of the sequencing device from qualified to expired qualification a predetermined period of time after the sequencing device was qualified. The processor is configured to send a warning to the client terminal prior to the expiration. The warning may be sent one week prior to the expiration.
[0022] In one aspect of the present disclosure, retained previous reports may be made public by authorized users.
[0023] In one aspect of the disclosure, the processor is further configured to determine whether the requested analysis is in research mode. If the analysis is determined to be in research mode, the processor is configured to allow access by the client terminal to a research analysis report generated by the processor even if the sequencing instrument is not qualified or the reagents used are not qualified.
[0024] In one aspect of the present disclosure, the system further comprises a user interface displayable on a client terminal. The user interface may be web-based. Reports generated by the processor (if not retained) may be accessed through the user interface. [The present invention 1001] 1. A system comprising: a memory configured to store an identifier of the sequencing instrument and an associated status including qualified or disqualified, an identifier of the reagent and an associated status including qualified and disqualified, and an identifier of approved software for the sequencing instrument; a network interface configured to communicate with the sequencing device and the client terminal; and 1. A processor comprising: receiving a report from the sequencing device via the network interface about the sequencing run, the report including an identifier of the sequencing device that generated the report, an identifier of reagents used in the sequencing run, an identifier of software installed on the sequencing device, and a result of the sequencing run; Determine whether the sequencing run has been designated as a qualification run It is structured as follows: If it is determined that the sequencing run has been designated as a qualification run, determining whether the software installed on the sequencing device is approved software by comparing an identifier of the software in the report with an identifier in memory, and if the software installed on the sequencing device is not approved, an associated status for the sequencing device is disqualified; examining the results of the sequencing run to determine whether the sequencing instrument or the reagents have been qualified; and In response to the survey, updating the associated status for the sequencing instrument and / or the reagents. The processor further comprises: [The present invention 1002] The system of the present invention 1001, wherein the processor is further configured to receive from the client terminal through the network interface a designation of a sequencing run as a qualification run, the designation including whether the qualification run performs qualification of the sequencing instrument, the reagents, or both the sequencing instrument and the reagents. [The present invention 1003] The system of the present invention 1002, wherein the processor is further configured to send a notification to the client terminal via the network interface indicating whether the sequencing instrument or the reagent has been qualified based on the qualification run. [The present invention 1004] the processor is further configured to determine whether the requested analysis is in a diagnostic mode; If the analysis is determined to be in a diagnostic mode, the processor further determining whether the software installed on the sequencing device is approved software by comparing an identifier of the software in the report with an identifier in memory; determining whether the sequencing device has been qualified based on the associated status stored in memory for the sequencing device identified in the report; and determining whether the reagents used in the sequencing run were qualified based on the associated status stored in memory for the reagents identified in the report; It is structured as follows: the processor is configured to retain in memory a diagnostic analysis report generated from the report if the software installed on the sequencing device is not approved or if the sequencing device and / or the reagents are not qualified. The system of the present invention 1001. [The present invention 1005] The system of the present invention 1004, wherein the processor is configured to allow the client terminal to access the diagnostic analysis report if the software installed on the sequencing device is approved and both the sequencing device and the reagents have been qualified, and allowing the access enables the diagnostic analysis report to be displayed by a user interface of the client terminal. [The present invention 1006] The system of the present invention 1004, wherein the processor is further configured to store an expiration date of each reagent in association with an identifier of the reagent, and to change the status of the reagent to disqualified if the current date is after the expiration date of the reagent. [The present invention 1007] The system of claim 1004, wherein the processor is further configured to send a notification to the client terminal via the network interface that the diagnostic analysis report has been retained. [The present invention 1008] The system of the present invention 1004, wherein the processor is further configured to send a notification to the client terminal via the network interface that the software installed on the sequencing device is not approved or that at least one of the sequencing device and the reagents have not been qualified. [The present invention 1009] The system of the present invention 1004, wherein the processor is further configured to disable generation of an analysis plan in the diagnostic mode if the software installed on the sequencing device is not approved or if the sequencing device has not been qualified. [The present invention 1010] The system of the present invention 1004, wherein the processor is further configured to receive, via the network interface, instructions to release a retained diagnostic analysis report, the instructions including an authentication passcode. [The present invention 1011] The system of the present invention 1001, further comprising a user interface, the user interface displayable on the client terminal, the user interface configured to display available sequencing instruments, the available sequencing instruments including qualified and disqualified sequencing instruments, and the user interface having a selection window allowing selection of a sequencing instrument and allowing selection of a sequencing run as a qualification run. [The present invention 1012] The system of the present invention 1011, wherein the user interface is accessible through a web browser on the client terminal, and the processor allows access to the user interface. [The present invention 1013] The system of the present invention 1012, wherein the user interface displays a qualification status of each sequencing device. [The present invention 1014] The system of the present invention 1001, wherein the associated status for the sequencing device further includes expired qualification, and when the sequencing device is determined to be qualified, a qualification date is stored in memory in association with an identifier of the qualified sequencing device, and the sequencing device remains qualified for a period of time designated as a qualification period, and the processor is further configured to determine when the period of time expires, and when it is determined that the period of time has expired, the processor is configured to change the associated status for the sequencing device to expired qualification. [The present invention 1015] The system of the present invention 1014, wherein the processor is further configured to send a notification to the client terminal through the network interface that the qualification period is about to expire, the sending occurring at a time before the period expires, and the notification is configured to cause a prompt to be displayed on a user interface displayable on the client terminal, the prompt indicating that a run of the sequencing device should be performed as a qualification run to perform qualification of the sequencing device. [The present invention 1016] The system of the present invention 1014, wherein the processor is further configured to receive, via the network interface, settings for the period and the time before the period expires, the settings including an authentication passcode. [The present invention 1017] The system of the present invention 1011, wherein the processor is further configured to receive information regarding a hardware update of the sequencing equipment, the information being entered into the user interface of the client terminal and communicated through the network interface, and the processor is configured to change the associated status of the sequencing equipment to disqualified in response to receiving the information. [The present invention 1018] The system of the present invention 1017, wherein the processor is configured to send a notification to the client terminal via the network interface when a change in the associated status of the sequencing device occurs, and the notification is configured to cause a prompt to be displayed on the user interface, the prompt indicating that a qualification run should be performed to perform qualification of the sequencing device. [The present invention 1019] The system of the present invention 1001, wherein the processor is further configured to determine whether the requested analysis is in research mode, and if the analysis is determined to be in research mode, the processor is configured to allow access by the client terminal to a research analysis report created by the processor from the report, and allowing the access enables display of the research analysis report by the user interface of the client terminal even if the sequencing equipment is not qualified or the reagents used are not qualified. [The present invention 1020] The system of the present invention 1001, wherein the memory further includes an identifier of a qualification material, the report further includes an identifier of the qualification material used to create the report, and the processor is configured to determine that the sequencing instrument is not qualified if the identifier of the qualification material used to create the report does not match the identifier of the qualification material stored in the memory. [The present invention 1021] 1. A system comprising: a memory configured to store an identifier of the diagnostic device and an associated status including qualified or disqualified, an identifier of the reagent and an associated status including qualified and disqualified, and an identifier of approved software for the diagnostic device; a network interface configured to communicate with the diagnostic equipment and the client terminal; and 1. A processor comprising: receiving a report from the diagnostic device via the network interface, the report including an identifier of the diagnostic device that generated the report, an identifier of a reagent used for the test parameter, an identifier of software installed on the diagnostic device, and a result of the test parameter; Determine if the test parameters are designated as a qualification run It is structured as follows: If it is determined that the test parameters are designated as a qualification run, determining whether the software installed on the diagnostic device is approved software by comparing an identifier of the software in the report with an identifier in memory, and if the software installed on the diagnostic device is not approved, an associated status for the diagnostic device is disqualified; examining the results of the test parameters to determine whether the diagnostic device or the reagent has been qualified; and In response to the survey, updating the associated status for at least one of the diagnostic device and the reagent. The processor further comprises: [Brief description of the drawings]
[0025] [Figure 1] FIG. 1 is a block diagram of a system according to an aspect of the present disclosure. [Diagram 2] FIG. 2 is a block diagram of a server according to an aspect of the present disclosure. [Diagram 3] FIG. 2 is a block diagram of a program memory according to an aspect of the present disclosure. [Figure 4] FIG. 2 is a block diagram of a working memory according to an aspect of the present disclosure. [Diagram 5] 1 is a flow chart of a method for qualifying, checking, and monitoring the use of sequencing equipment and reagents in accordance with an aspect of the present disclosure. [Figure 6] 1 is a flow chart of a method for qualifying, checking, and monitoring the use of sequencing equipment and reagents in accordance with an aspect of the present disclosure. [Figure 7] 1 is a flow chart of a method for qualifying, checking, and monitoring the use of sequencing equipment and reagents in accordance with an aspect of the present disclosure. [Figure 8]1 is a flow chart of a method for qualifying, checking, and monitoring the use of sequencing equipment and reagents in accordance with an aspect of the present disclosure. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0026] Detailed Description Although this detailed description illustrates a system that utilizes a sequencing device as a diagnostic device, it will be understood that the systems, methods, and programs described herein may utilize different types of diagnostic devices.
[0027] As used herein, a "diagnostic instrument" may include any instrument that may be used to perform diagnostic tests such as those performed in a clinical research environment. Such tests may include immunoassays, clinical chemistry assays, and / or molecular diagnostic assays, and the like. For example, in embodiments, a diagnostic instrument may be capable of performing immunoassays, including, for example, enzyme-linked immunosorbent assays (ELISAs), chemiluminescent immunoassays, fluorescent immunoassays, colorimetric immunoassays, radioimmunoassays, rapid tests, Western blotting, and / or enzyme-linked immunospot assays. In some embodiments, a diagnostic instrument may be capable of performing clinical chemistry assays, including detection of analytes, for example, processing of diagnostic panels, including panels of metabolic, electrolyte, liver, lipid, renal, and / or thyroid function. In embodiments, a diagnostic instrument may be capable of performing molecular diagnostic assays, including, for example, polymerase chain reaction (PCR), isothermal nucleic acid amplification techniques, microarray assays, hybridization assays, nucleic acid sequencing, and next-generation nucleic acid sequencing and / or third-generation nucleic acid sequencing. In embodiments, the diagnostic device may be capable of performing microbiological, hematological, coagulological, hemostasis and / or urinalysis assays. In embodiments, the diagnostic device may be capable of performing mass spectrometry, proteomics, microbiome analysis and / or tumor microenvironment analysis.
[0028] Furthermore, in various embodiments, a diagnostic instrument may be capable of performing a single diagnostic test or a combination of diagnostic tests. Thus, a diagnostic instrument may be capable of performing immunoassays as well as clinical chemistry assays. An example of an instrument capable of performing multiple diagnostic tests is a hematology analyzer that may utilize either electrical impedance (resistance), then flow cytometry and light scatter, or fluorescence flow cytometry and fluorescence detectors to count, differentiate, and evaluate red blood cells (RBCs), white blood cells (WBCs), and platelets.
[0029] Thus, the present disclosure provides systems, methods, and programs configured to check, record, and qualify the use of diagnostic equipment and associated reagents, consumables, and / or disposable components to ensure that performance and quality meets or exceeds standards for IVD use.
[0030] FIG. 1 is a block diagram of a system 1 according to an embodiment of the present disclosure. The system 1 includes a plurality of sequencing instruments 10. 1~N (hereinafter, referred to as "10"), a client terminal 20, and a server 30. The client terminal 20 can communicate with the server 30. In one embodiment of the present disclosure, the communication may be through a wireless network such as a Local Area Network (LAN).
[0031] The client terminal 20 may include a web browser for accessing a user interface (web-based UI) that communicates with the server 30. The user interface is used at least to specify an analysis plan for a sequencing run, to set up the sequencing run as a qualification run to qualify the sequencing instrument 10 and / or reagents (among other features), and to display or retrieve a server analysis report. The user interface is described below. In one embodiment of the present disclosure, the client terminal 20 communicates with the server 30 through the Internet. However, in other embodiments of the present disclosure, application programs may be downloaded locally to the client terminal 20 and the user interface may be stored locally. Also, the client terminal 20 may be a mobile terminal such as a laptop or a mobile phone (smartphone), or may be a desktop computer.
[0032] The sequencing instrument 10 is configured to perform an assay run. The sequencing instrument 10 may be an off-the-shelf sequencing instrument. For example, the sequencing instrument may be a commercially available instrument from Illumina®. The sequencing instrument 10 may be configured for diagnostic or research use (depending on the type).
[0033] Each sequencing device 10 includes multiple pieces of software (software packages). This software may be pre-installed. Alternatively, the software may be updated. The software is identified by an identifier that includes a version number.
[0034] After a sequencing run (also referred to as a run or a sequencing run) is performed on the sequencing instrument 10, the sequencing instrument 10 generates a sequencing instrument report and transmits it to the server 30. In one embodiment of the present disclosure, each sequencing instrument 10 communicates with the server 30 through a wireless network, such as a LAN. The sequencing instrument report includes information regarding the run information. The run information may include a report including at least an identifier for the sequencing instrument, an identifier for the installed software, a date of the run, and a start date and time, a lot number of reagents used in the run, a unique identifier for the run, and a result of the run. The result of the run may include a quality score, such as but not limited to a Q30 score. The report of a sequencing instrument run may include other information not specifically disclosed herein.
[0035] The term reagent includes reagent kits, flow cells, and PR2 bottles. Each reagent is identified by a lot number.
[0036] The server 30 communicates with the client terminal 20. This communication is bidirectional, meaning that the server 30 may receive information from the client terminal 20 and may send information to the client terminal 20.
[0037] 2 is a block diagram of the server 30. The server 30 includes a CPU 200, a memory 205, and a network interface 210.
[0038] The memory 205 includes a program memory 207 and a working memory 208. The CPU 200 is configured to execute programs (also described herein as modules or instructions) stored in the program memory 207 to perform the functions described herein. The memory 205 may be, but is not limited to, a RAM, a ROM, or a persistent storage device. The memory 205 is any piece of hardware that can store persistent storage information, such as, but not limited to, data, programs, instructions, program code, and / or other suitable information, either in a temporary manner and / or a permanent manner.
[0039] 2, the server 30 may include other types of processors, such as a GPU. In other aspects of the disclosure, instead of or in addition to the CPU 200 executing instructions programmed into the program memory 207, the processor may be an ASIC, analog circuitry, or other functional logic, such as an FPGA, PAL, or PLA.
[0040] The program memory 207 (shown in FIG. 3) may include one or more programs. For example, the program memory 207 may include a sequencing analysis program 304. The sequencing analysis program 304 may include instructions that cause the CPU 200 to execute an analysis plan on the sequencing instrument reports received from the sequencing instrument 10.
[0041] The sequencing analysis program 304 may also include instructions to display a web-based UI on the client terminal 30. For example, the web-based UI includes a login screen that accepts a user identifier and a passcode. In one aspect of the present disclosure, the login screen allows a user to select different system modes (e.g., analysis mode). For example, the modes include at least a diagnostic mode and a research mode. In other aspects of the present disclosure, the modes may also include a research mode. Consistent with these aspects, the server may treat the research mode in the same manner as the diagnostic mode.
[0042] The web-based UI includes screens for creating analysis plans for different modes. The analysis plans for different modes are different.
[0043] The software module for the web-based UI may be separate from the software module that executes the analysis plan. In other aspects of the present disclosure, the modules may be integrated into a single platform.
[0044] The program memory 207 further includes a qualification / tracking program 302. The qualification / tracking program 20 includes instructions that are executed by the CPU 200. The instructions cause the server 30 to display an additional web-based UI on the client terminal 20, determine if the sequencing instrument 10 has been qualified, determine if the reagents have been qualified, control access to the server analysis reports, and update the status of the sequencing instrument and reagents as necessary.
[0045] The software module for the web-based UI may be separate from the software module that determines whether the sequencing instrument 10 has been qualified, determines whether the reagents have been qualified, controls access to the server analysis reports, and updates the status of the sequencing instrument and reagents as necessary.
[0046] In addition, a qualification / tracking program 302 and a sequencing analysis program 304 may be integrated into the platform.
[0047] The qualification / tracking program 302 has instructions for creating a web-based UI for sequencing instruments, reagents, analysis plans, sequencing runs, and cases.
[0048] For example, a web-based UI for sequencing instruments may include a list (identifiers) of sequencing instruments and associated status. The status may be unqualified, qualified, and expired qualification. Expired qualification means that the sequencing instrument has been qualified, but it has been a set period of time since the sequencing instrument was qualified. In another aspect of the present disclosure, the status may include untested. The status may be displayed differently so that the user recognizes the difference in status. In one aspect of the present disclosure, different colors may be used for different statuses. For example, qualified may be displayed in green, e.g., the word qualified may be displayed in green, and unqualified or expired qualification may be displayed in red, e.g., the word unqualified or expired qualification may be displayed in red. In another aspect of the present disclosure, the identifier may be displayed in red or green depending on the status.
[0049] In another aspect of the present disclosure, the web-based UI may include the time remaining until the eligibility check expires.
[0050] The list may be in the form of a table with column headings.
[0051] A separate web-based UI for the sequencing instrument may include information about its last run, such as the timing of the last run. This UI may take the form of a pop-up screen when the sequencing instrument is selected from the web-based UI for the sequencing instrument.
[0052] In other aspects of the present disclosure, a separate web-based UI for the sequencing instrument may include quality scores for the qualification runs.
[0053] The web-based UI for the reagents may include a list of reagents (identified by lot number). The list may include the type of reagent, such as kit, flow cell, PR2 bottle, etc., and its associated status. The status may be unqualified and qualified. In other aspects of the present disclosure, the web-based UI may also include an expiration date for the reagent and an indication that the reagent has expired. As with the sequencing instrument 10, the status of the reagent may be displayed differently to make the user aware of the difference in status. In one aspect of the present disclosure, different colors may be used for different statuses. For example, qualified may be green, e.g., the word qualified may be displayed in green, and unqualified may be red, e.g., the word unqualified may be displayed in red. In another aspect of the present disclosure, the identifier may be displayed in red or green depending on the status. In another aspect of the present disclosure, expired lots may be identified with the word expired in a particular color, such as, but not limited to, red.
[0054] The list may be in the form of a table with column headings.
[0055] Another web-based UI for a reagent may include the qualification date and the quality score for the qualification run.
[0056] The web-based UI for the Run Level Server Analysis Report (also referred to herein as the Analysis Plan Report) may include the sequencing run plan name, description, and start date. In one embodiment of the present disclosure, the web-based UI will also have an indication of whether a complete run report has been retained (a complete run record is created by the server 30 for the sequencing run). For example, the indication may be a color or specific wording. In another embodiment of the present disclosure, the reason why the complete run report is being retained may be included. The reason may indicate that the sequencing instrument or reagents were not qualified at the time of the sequencing run, or that the reagents used are expired.
[0057] A web-based UI may be displayed for the case. This web-based UI may include a case number, a start date of the sequencing run, a plan name, and an assay name. In other embodiments, the web-based UI may also include the name of the test sample used. A sequencing run may have multiple cases. In one embodiment of the present disclosure, there is a separate case for each test sample in a sequencing run. In other embodiments of the present disclosure, multiple test samples (from a sequencing run) may be included in a single case. In one embodiment of the present disclosure, the web-based UI will also have an indication of whether a Diagnostic Analysis Report has been retained (a Diagnostic Analysis Report is generated by server 30 for each test sample (case) included in the analysis plan).
[0058] The web-based UI for a run may include an identifier for the run, the start date and time of the run, the status (sequencing in progress or failed), and whether the run is a qualification run. In one aspect of the present disclosure, if the run is a qualification run, the web-based UI may also have an indication of the status of the qualification run (e.g., passed or failed). In another aspect of the present disclosure, a quality score for the run may be included in the web-based UI.
[0059] In one aspect of the disclosure, the web-based UI for the run may also include a selection tool for selecting the run as a qualification run. The selection tool may be a check box, a button, or a slide switch. The slide switch may be configured, for example, to move from a first position to a second position indicating the run has been selected as a qualification run.
[0060] In one aspect of the present disclosure, if a run is selected as a qualification run, a separate web-based UI may be displayed. This web-based UI may include a separate selection tool that identifies what qualification to perform (e.g., only the sequencing instrument, only the reagents, or both the sequencing instrument and the reagents). This selection tool may be a radio dial, multiple checkboxes, or multiple buttons. This web-based UI may be displayed as a pop-up window (also referred to herein as a pop-up).
[0061] In another aspect of the disclosure, another web-based UI may be displayed when a run is selected as a qualification run. This web-based UI may be an alert or warning that confirms the user's desire to proceed with the run as a qualification run. For example, the web-based UI may be a pop-up window. The pop-up window may read, "Marking this run as a qualification run will run analyses that will mark the sequencer and reagent lots as qualified or disqualified. Any assays run on a disqualified sequencer or with a disqualified reagent lot will have their reports retained. Are you sure you want to continue?" (sequencer may be replaced with sequencing equipment). Other wording may be used and is not limited to the examples described herein.
[0062] In one embodiment of the present disclosure, only sequencing runs that have been completed may be marked or designated as qualification runs. Sequencing runs that have failed may not be marked as qualification runs.
[0063] In another aspect of the disclosure, a separate web-based UI may be displayed when a run is selected as a qualification run. This web-based UI may be displayed only if an administrator is logged in. The administrator may deselect the run as a qualification run. The administrator may deselect the run using a selection tool in a manner similar to that described above. The web-based UI may be a pop-up window as an alert or warning confirming the administrator's desire to deselect the run. For example, the pop-up may read, "Unmarking this run as a qualification run may change which sequencers and / or reagent lots are marked as qualified. Are you sure you want to continue?" (sequencer may be replaced with sequencing instrument). Other wording may be used and is not limited to the examples described herein.
[0064] In one aspect of the present disclosure, the types of web-based UIs may be accessible through different tabs or buttons on the main web-based UI, while in other aspects of the present disclosure, the types of web-based UIs may be separate UIs.
[0065] In one aspect of the disclosure, the listings for each web-based UI may be ordered from most recent to oldest, for example, a web-based UI for sequencing runs may list the most recent sequencing runs first and the oldest last.
[0066] The program memory 207 may also include a host web server program 300, which allows the server to accept and respond to HTTP requests.
[0067] The working memory 208 contains information used by the qualification / tracking program 302 and the sequencing analysis program 304 .
[0068] The working memory 208 includes the model number and approved for use software 324. The model number is for the sequencing instrument 10. The model number is specific to the manufacturer. The software is the type of software installed on the sequencing instrument 10, including the version number. The software can include sequencing instrument control software and primary analysis software. The model number and software 324 may be entered into the server 30 by an authorized user, such as an authorized technician, system installer, or system administrator. In one embodiment of the present disclosure, the model number and software 324 is entered prior to installation of the system 1 and prior to use of the system. In other embodiments of the present disclosure, the model number and software 324 is entered into the server 30 at the time of installation, during the configuration phase. As new makes (models) become available from the manufacturer or new software and software versions are produced, additional model numbers and software 324 may be added as needed through updates by authorized users. In one embodiment of the present disclosure, adding the model number and software requires authentication through a user name and passcode.
[0069] The model number and software 324 stored on the server 30 are subsequently used to determine whether the sequencing device 10 that generated the sequencing device report has approved software installed and is an approved make (model).
[0070] The working memory 208 also includes identifiers for materials approved for use in qualifying either the sequencing instrument 10 and / or reagents (referred to herein as qualification materials 326). In one aspect of the present disclosure, the qualification materials 326 are diverse sequencing materials derived from a bacteriophase source, manufactured with adaptors. The qualification materials 326, when pooled with other controls / samples, are used to track sequencing metrics.
[0071] Like the model number and software 324, the qualification materials 326 may be entered into the server 30 prior to or during installation by an authorized user, such as an authorized technician, system installer, or system administrator.
[0072] The identifier of the qualification material stored on the server is subsequently used to determine whether the run selected as a qualification run used the appropriate qualification material.
[0073] The working memory 208 also includes information about the sequencing instrument (e.g., referred to herein as "310"). In one embodiment of the present disclosure, the identifier of the sequencing instrument 10 may be manually entered by an authorized user at the time of installation, e.g., registering the sequencing instrument 10 with the server 30. The information about the sequencing instrument (e.g., 310) may include the identifier of the sequencing instrument, its qualification status, the qualification date, the qualification expiration date, and when to warn of impending expiration. In other embodiments of the present disclosure, the information 310 may also include the date and time of the last run. When the sequencing instrument 10 is initially registered, the qualification status is set to not qualified or not tested, and the date and time of the last run is not implemented. In one embodiment of the present disclosure, the information may also include a quality score of the qualification run.
[0074] Each time a new sequencing device 10 is added to the system 1, the sequencing device is registered and information is added to the working memory (information 310). In other aspects of the present disclosure, the sequencing device's identifier may be added through a radio frequency identification reader, such as a bar code reader.
[0075] In another aspect of the present disclosure, the sequencing device identifier is added when the sequencing device report is received from the sequencing device 10. In this case, the sequencing device 10 is not pre-registered.
[0076] In one embodiment of the disclosure, each sequencing device 10 has its own record in the working memory 208. In another embodiment of the disclosure, all sequencing devices are maintained as a list. The information may be contained in a table.
[0077] The information in the working memory 208 for a sequencing device (e.g., 310) is used by the server 30 to create the above-mentioned web-based UI for the sequencing device, to determine if the sequencing device is qualified when it performs a sequencing run, to determine if the qualification has expired, and to determine when to issue a warning that the qualification is about to expire. If necessary, the server 30 updates the status information based on the qualification run, e.g., from unqualified to qualified and vice versa (and from qualified to expired qualification). The most recent qualification run governs the status.
[0078] The working memory 208 also includes information about the reagent (e.g., 312). In one embodiment of the present disclosure, certain information about the reagent may be manually entered by an authorized user. For example, an authorized user may enter a lot number (identifier), a type of reagent, and an expiration date of the reagent. In one embodiment of the present disclosure, the information about the reagent 312 may include its qualification status, including disqualified, qualified, and not tested. When a reagent is initially registered, the qualification status is set to disqualified or not tested. In one embodiment of the present disclosure, the information 312 may also include a quality score of a qualification run having the reagent. In other embodiments of the present disclosure, a qualification date is included in the information 312. The quality score, qualification status, and qualification date are automatically entered by the server 30.
[0079] Each time a new reagent is added to the system 1, the reagent is registered and information is added to the working memory (information 312). In other aspects of the disclosure, the reagent lot number, type, and expiration date may be added via a radio frequency identification reader, such as a bar code reader.
[0080] In another aspect of the present disclosure, the reagent lot number, type, and expiration date are added when receiving the sequencing instrument report from the sequencing instrument 10. In this case, the reagents are not pre-registered.
[0081] In one embodiment of the present disclosure, each reagent has its own record in the working memory 208. In another embodiment of the present disclosure, all of the reagents are maintained as a list. The information may be contained in a table.
[0082] The information in the working memory 208 for a reagent (e.g., 312) is used by the server 30 to generate the above-mentioned web-based UI for the reagent, to determine whether the reagent has been qualified when a sequencing run is performed by the sequencing instrument 10, and to determine whether the reagent has expired. If necessary, the server 30 updates the status information based on the qualification run, e.g., from unqualified to qualified and vice versa (and qualified to expired qualification). The most recent qualification run governs the status.
[0083] The working memory 208 also includes a sequencing device report 318. The sequencing device report 318 is a report received from the sequencing device 10. In addition to the information described above, the sequencing device report may also include an indication of whether the sequencing was completed or failed. The sequencing device report 318 may be stored in the working memory 208 for a preset period of time. The preset period may be based on the size of the working memory 208.
[0084] The information in the sequencing instrument report is subsequently used to determine whether the sequencing instrument 10 and reagents have been qualified (by comparing the information in the report with the information in the sequencing instrument and reagent areas (310 and 312, respectively) in the working memory 208).
[0085] The working memory 208 also includes a run history 314. A record is kept for each sequencing run (e.g., each sequencing instrument report). The run history 314 is created from the sequencing instrument report 318 and information entered through the web-based UI at the client terminal 20. For example, for each run, the history may include a unique identifier for the run, the date and time the run started on the sequencing instrument, an identifier for the sequencing instrument, and whether the sequencing completed or failed. This information is automatically entered by the server 30 from the sequencing instrument report 318.
[0086] In one embodiment of the present disclosure, the run history 314 may further include whether the run was selected as a qualification run, and if so, whether the qualification passed or failed. In one embodiment of the present disclosure, the information about the qualification run includes whether the run was selected to perform qualification of only the sequencing instrument, only the reagents, or both the sequencing instrument and the reagents. In another embodiment of the present disclosure, the run history 314 may include information about whether the sequencing run was performed on a disqualified sequencing instrument or with disqualified reagents. In other embodiments of the present disclosure, the run history 314 may further include a quality score. In other embodiments of the present disclosure, the run history 314 may further include expiration dates for the reagents. In one embodiment of the present disclosure, the run history may include a complete run report.
[0087] The run history 314 may be used by the server 30 to generate certain of the web-based UIs described above.
[0088] The working memory 208 also includes a case history 328. The case history includes all cases that have been analyzed on the server 30 since installation. The case history may also include case reports, such as diagnostic analysis reports and laboratory analysis reports. The case history 328 stored in the working memory 208 is used by the server 30 to generate certain of the web-based UIs described above.
[0089] The working memory 208 also includes an analysis plan 316. The analysis plan 316 is created by a user at the client terminal 20 using a web-based UI. The user may generate the analysis plan 316 once logged in. The type of analysis may be determined by the mode of login, e.g., diagnostic verse research. In diagnostic mode, the user may create a plan for diagnostic analysis, and in research mode, the user may create a plan for research analysis. In other aspects of the disclosure, the user may specify a mode, e.g., diagnostic mode or research mode, in the analysis plan.
[0090] The analysis plan 316 includes an assay identifier, a sequencing run (unique identifier), a plan name, and a plan description. The analysis plan 316 may also include samples (and sample types, e.g., external controls and analytes). The analysis plan 316 stored in the working memory 208 is used by the server 30 to generate certain of the web-based UIs described above.
[0091] The working memory 208 also includes server analysis reports 322. The server analysis reports 322 are reports generated by the server 30 using the sequencing analysis program 304 (using the data in the sequencing instrument report 318 stored in the working memory 208) based on a user-defined analysis plan 316 for the sequencing run. The server analysis reports 322 include a complete run report (run-level report), a diagnostic analysis report (case-level report) in the case of a diagnostic mode, and a study analysis report (case-level report) in the case of a study mode. In one aspect of the present disclosure, the server 30 may generate analysis reports for a qualification run for which an analysis plan has also been created.
[0092] In accordance with an embodiment of the present disclosure, the server 30 (CPU 200 executing the qualification / tracking program 302) may retain the diagnostic analysis report / prevent access to the diagnostic analysis report via any web-based UI if a sequencing run (included in the report) was performed by a disqualified sequencing instrument or if the sequencing run used a disqualified reagent.
[0093] The working memory 208 also includes the user names / passcodes of registered users. There are different types of registered users based on their usage rights. The system 1 has layered or hierarchical rights. For example, an authorized server installer or server technician may have the most rights. These rights may include updating approved sequencing types, software 324, and qualification materials 326, among others. An administrator may have a set of rights less than the above. These rights may include publishing retained / restricted diagnostic analysis reports, removing runs from a qualification run, changing the qualification period of a sequencing instrument, and changing warning times. Rights may also include adding (e.g., registering) sequencing instruments 10 and reagents. A regular or regular user may have fewer rights that do not include the activities identified above, but do include browsing the web-based UI, selecting sequencing runs as qualification runs, reviewing published server analysis reports, and creating analysis plans.
[0094] Administrators and authorized server installers or technicians have all the rights of regular or normal users.
[0095] 5-8 are flow charts of methods for qualifying, checking, and monitoring the use of sequencing instruments and reagents in accordance with embodiments of the present disclosure. The functions illustrated in FIGS. 5-8 are performed by a server 30 (CPU 200) executing a program stored in a program memory 207. This specification may use the server 30 or the CPU 200 when describing the functions.
[0096] The functions may be performed in an order other than that shown, and certain functions may be performed simultaneously. For example, receiving the sequencing instrument report 318 from the sequencing instrument 10 may occur simultaneously with the user logging in at S502. Also, the analysis plan may be generated before, during, or after the sequencing run. If the analysis plan is generated before or during the sequencing run, the server identifies the analysis plan using the reagent lot number. If the analysis plan is generated after the sequencing run, the web-based UI will have a list of available sequencing runs. This list may take the form of a drop-down window to select a sequencing run.
[0097] In S500, the server 30 receives the sequencing device report 318 from the sequencing device 10. The server 30 receives the report through the network interface 210 (which may be a wireless interface). The CPU 200 stores the report 318 in the working memory 208.
[0098] Prior to S502, the server 30 receives a request to display a web-based UI for logging in to the system 1. The server 30 transmits the web-based UI for display to the client terminal 20. In the client terminal 20, a user inputs a URL for the server using a web browser.
[0099] In S502, the server 30 receives a user ID and passcode entered by the user (through the network interface 210). In S504, the CPU 200 compares the received user ID and passcode with the user name and passcode 320 stored in the working memory 208 to determine whether there is authorized access. If there is no match (S504: No), the user is denied access to the system 1 in S505. The server 30 sends a login failure message. If there is a match (S504: Yes), the CPU 200 determines the associated rights, e.g., authorized installer, administrator, or normal user. In S506, the CPU 200 displays a web-based UI permitted for a particular type of user. In one aspect of the present disclosure, when a user logs in, the user selects a particular mode (diagnosis or research), and thus, in accordance with this aspect of the present disclosure, S506 also includes displaying a web-based UI for the selected mode. The web-based UI is transmitted by the network interface 210. As described above, the web-based UI is displayed using information in working memory 208. For example, the web-based UI for a run is displayed according to information in run history 314. The web-based UI for a sequencing instrument is displayed according to information for the sequencing instrument (310), and the web-based UI for a reagent is displayed according to information for the reagents 312.
[0100] As described above, a user may generate an analysis plan 316 through the web-based UI and may designate a sequencing run as a qualification run for the sequencing instrument only, reagents only, or both the sequencing instrument and reagents. A sequencing run may be designated as a qualification run through the web-based UI for the run or within the analysis plan itself.
[0101] In S508, the server 30 receives the analysis plan 316 (with or without a designation of a qualification run). In one embodiment of the present disclosure, the server 30 may receive a separate designation of a qualification run. The CPU 200 stores the analysis plan 316 in the working memory 208. In one embodiment of the present disclosure, if the user designates the sequencing run as a qualification run, the analysis plan 316 may not be received. In other embodiments of the present disclosure, the analysis plan 316 may be created for a run designated as a qualification run if the sequencing run includes samples in addition to the qualification material 326. When an analysis plan is generated for a run designated as a qualification run, in one embodiment of the present disclosure, an analysis may be performed first to determine whether the sequencing equipment and reagents have been qualified.
[0102] In S510, the CPU 200 determines whether the sequencing run has been designated as a qualification run, for example, whether the server 30 has received a designation from a web-based UI or whether the analysis plan 316 indicates that the sequencing run is a qualification run.
[0103] If the CPU 200 determines that the sequencing run is designated as a qualification run, S600 is executed. FIG. 6 illustrates a qualification analysis. In S600, the CPU 200 determines what the user specified for the qualification run, for example, sequencing instrument only, reagent only, or both sequencing instrument and reagent. In one embodiment of the present disclosure, the reagent may be qualified on a different sequencing instrument and thus may not need to be qualified again. Additionally, in one embodiment of the present disclosure, the sequencing instrument 10 may have been qualified with a different reagent and thus may not need to be qualified again unless the qualification expires.
[0104] If the CPU 200 determines that the user specified a sequencing run that qualifies only the sequencing instrument, the CPU 200 performs an analysis on only the sequencing run. The CPU 200 retrieves the sequencing instrument report 318 for the sequencing run from the working memory 208. In S602, the CPU 200 identifies the model number and software (and version) installed on the type of sequencing instrument 10 that generated the report for the sequencing run. The CPU 200 also retrieves the model number and software 324 that are approved and stored in the working memory 208. The CPU 200 compares (in S604) the sequencing instrument model number and installed software (and version) with the approved model number and software 324 to determine whether the type and software (for the sequencing instrument) are approved.
[0105] If CPU 200 determines that the model number and / or software (and version) does not match the approved information in working memory ("No" at S604), the sequencing instrument is not qualified and the status for the sequencing instrument is set to (or remains) disqualified at S606. CPU 200 updates the status information (stored in 310) for the sequencing instrument to disqualified. CPU 200 also updates run history 614 for the sequencing run.
[0106] In S608, CPU 200 displays a notification in the web-based UI that the sequencing instrument has been disqualified. In one embodiment of the present disclosure, if the user is still logged into system 1, the web-based UI is updated with the change in status. In one embodiment of the present disclosure, if the user has logged out of system 1, a subsequent login may result in an update of the web-based UI for the sequencing instrument and the run. In another embodiment of the present disclosure, a pop-up window may be displayed.
[0107] In one embodiment of the present disclosure, the CPU 200 may disable the selection of the diagnostic mode analysis in S620. This is because the system 1 does not include a qualified sequencing device 10. 1~N is not present. In this aspect of the disclosure, if the user subsequently attempts to log into system 1, the web-based UI for logging in may not include a "diagnostic mode" (only) button. In other aspects of the disclosure, the web-based UI may include a button, but the button may be displayed as unselectable. In other aspects of the disclosure, CPU 200 may inhibit the web-based UI from generating an analysis plan for the diagnostic analysis rather than affecting the login process.
[0108] In another aspect of the disclosure, the CPU 200 may cause the web-based UI to display a warning when a sequencing device is selected during analysis plan generation, rather than disabling the selection of diagnostic mode analysis if the sequencing device has been disqualified. The web-based UI may be a pop-up window with a button or selection tool to select the sequencing device even if the sequencing device has been disqualified.
[0109] If the CPU 200 determines that both the model number and the software (and version) match the approved information in the working memory ("Yes" in S604), the CPU 200 then determines whether the proper qualification materials were used. In S610, the CPU 200 compares the identifiers of the qualification materials (as identified in the report) used to create the sequencing instrument report 318 with the qualification materials 326 stored in the working memory 208. If the CPU 200 determines that the proper materials were not used, e.g., there is a mismatch ("No" in S610), the CPU determines that the sequencing instrument has been disqualified (or remains disqualified), and S606 to S610 are executed. S606 to S610 have been described above and will not be described again.
[0110] If CPU 200 determines that appropriate materials were used, e.g., a match ("Yes" at S610), CPU 200 then examines the quality score for the sequencing run. For example, the Q30 score may be used to determine qualification. The examination may be based on other statistical parameters or quality metrics, and the present disclosure is not limited to only the use of quality scores. For example, qualification may also be determined by the total yield of amplified nucleic acid for the sequencing run.
[0111] A quality score for the sequencing run is generated by the sequencing instrument 10 and included in the sequencing instrument report 318. At S614, the CPU 200 compares the quality score (or any other statistical parameter) to a pre-set threshold. The pre-set threshold is stored in the memory 205. For example, the pre-set threshold may be between 70% and 80%, such as 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, or 80%. Other pre-set thresholds may be used, and the disclosure is not limited to the disclosed thresholds.
[0112] If the CPU 200 determines that the statistic, e.g., Q30, is less than the preset threshold ("Yes" in S614), the CPU 200 determines that the sequencing device has been disqualified (or remains disqualified), and S606 to S610 are executed. S606 to S610 have been described above and will not be described again.
[0113] If CPU 200 determines that a statistic, e.g., Q30, is greater than or equal to a preset threshold ("No" at S614), CPU 200 determines that the sequencing instrument is qualified (or remains qualified). At S616, CPU 200 sets the status of the sequencing instrument that performed the sequencing run to qualified. CPU 200 updates the status information (stored in 310) about the sequencing instrument to qualified. CPU 200 also updates run history 314.
[0114] In an embodiment, both the Q30 score and the total yield of amplified nucleic acid are used to determine qualification. When both are used, the preset threshold for the Q30 score is between 70% and 80%, e.g., 75%, and the preset threshold for the total yield is between 85% and 95%, e.g., 90%. In one embodiment, if the CPU 200 determines that the Q30 is equal to or greater than the preset threshold of 75% and the total yield is equal to or greater than the preset threshold of 90%, the sequencing run is qualified.
[0115] In S618, the CPU 200 displays a notification in the web-based UI that the sequencing device has been qualified. In one aspect of the present disclosure, if the user is still logged in to the system 1, the web-based UI is updated with the change in status. The CPU 200 then returns to S512.
[0116] If only the reagent is selected by the user, a similar qualification analysis is performed on the reagent. For example, S602, S604, and S610 are identical. If the model number and software are approved and the qualification materials are appropriate ("Yes" in S604 and S610), the CPU 200 checks the expiration date of the reagent to be used in the sequencing run in S628. The CPU 200 obtains the lot number to be used in the sequencing run from the stored sequencing instrument report 318 and retrieves the reagent information of the corresponding reagent from the working memory 208 (stored in the reagent 312). In S630, the CPU 200 compares the current date with the expiration date. The CPU 200 has a clock with a date. If the current date is later than the expiration date, the reagent is expired. If the reagent is determined to be expired ("Yes" in S630), the CPU 200 proceeds to S622.
[0117] CPU 200 also examines the quality scores (statistical parameters) of the sequencing runs in the same manner as described above for S612 and 614.
[0118] If CPU 200 determines that the statistic, e.g., Q30, is equal to or greater than a preset threshold, CPU 200 determines that the reagent is qualified (or remains qualified). In S632, CPU 200 sets the status of the reagent used in the sequencing run to qualified. CPU 200 also updates the reagent status information (stored in 312) to qualified. CPU 200 also updates run history 314.
[0119] In S618, the CPU 200 displays a notification in the web-based UI that the reagent has been qualified. In one embodiment of the present disclosure, if the user is still logged in to the system 1, the web-based UI is updated with the change in status. The CPU 200 then returns to S512.
[0120] If the model or software is not approved, or the qualification materials are not appropriate, or the reagent is expired, or the quality score is below a preset threshold ("No" at S604 and S610, "Yes" at S630 and S614), the CPU sets the status for the reagent to disqualified (or remains disqualified) at S622. The CPU 200 updates the status information for the reagent (stored at 312) to disqualified. The CPU 200 also updates the run history 314.
[0121] In S624, the CPU 200 displays a notification in the web-based UI that the reagent has been disqualified. In one aspect of the present disclosure, if the user is still logged into the system 1, the web-based UI is updated with the status change.
[0122] In one aspect of the present disclosure, if a reagent has been disqualified for any reason, the server 30 may prevent a diagnostic analysis using that reagent. In S626, the CPU 200 may remove the disqualified reagent from a list of available reagents to be included in the analysis plan. In one aspect of the present disclosure, the web-based UI for generating the analysis plan may include a drop-down window with a list of available reagents. The list may be created using information from the reagents 312 (for qualified reagents only). Thus, in accordance with an aspect of the present disclosure, a user may be prevented from selecting a disqualified reagent for an analysis plan.
[0123] In another aspect of the present disclosure, if it is determined that a reagent has expired, the CPU 200 may display a pop-up window as a web-based UI indicating that the reagent has expired along with instructions to discard the reagent. The pop-up window may have a confirm button and an ignore button.
[0124] If the user specifies a sequencing run that performs qualification of both the sequencing instrument and the reagents, then both sets of analyses are performed and are not described again. If the functions are identical for the reagents and the sequencing instrument, then the functions may only be performed once. For example, S602 may be performed when both the sequencing instrument and the reagents are selected for qualification.
[0125] Returning to FIG. 5, if CPU 200 determines that the user did not designate the sequencing run as a qualification run ("No" at S510) and an analysis plan 316 is received for the sequencing run, CPU 200 determines the mode for analysis at S514. In one aspect of the disclosure, the determination may be based on the login mode, for example, whether the user selected diagnostics or research upon login. In other aspects of the disclosure, the determination is based on information in the analysis plan.
[0126] In S516, the CPU 200 determines whether the analysis mode is a diagnostic mode. If the mode is determined to be a research mode, the CPU 200 performs the analysis as described in the analysis plan 316 and generates a study analysis report and a complete run report for the cases included in the analysis plan and stores them in the working memory 208 (at 322). A study analysis report is generated for each case in the analysis plan. In S518, the CPU 200 allows access to the study analysis report and the complete run report even if the sequencing run was performed on a sequencing instrument that was disqualified or with a reagent that was disqualified. In one embodiment of the present disclosure, the CPU 200 updates at least the case history 328 with the status of the available reports. The case history may also include the study analysis report generated for each case in the analysis plan. In one embodiment of the present disclosure, the analysis plan is updated with the complete run report in the working memory. In one embodiment of the present disclosure, an identifier for the storage location may be included. In one aspect of the present disclosure, if the user is still logged into system 1, the web-based UI is updated with the status change for the generated report. In one aspect of the present disclosure, if the user is logged out of system 1, a subsequent login may result in an update of the web-based UI for the run-level server analysis report, analysis plans, and cases. In another aspect of the present disclosure, a pop-up window may be displayed.
[0127] If the mode is determined to be diagnostic mode, CPU 200 executes the diagnostic analyses as described in the analysis plan and generates diagnostic analysis reports for each case in the analysis plan 316 and a complete run report for the sequencing run. The generated reports are stored in working memory 208 (server analysis reports 322).
[0128] CPU 200 also determines whether the diagnostic analysis report and / or the complete run report should be retained or made available for access. This determination is illustrated in FIG. 7. At S700, CPU 200 checks the model number of the sequencing instrument and the software (and version) installed thereon. CPU 200 identifies from report 318 the model number and the software (and version) installed on the sequencing instrument that created sequencing instrument report 318 for the sequencing run. CPU 200 also retrieves the model number and software 324 that is approved and also stored in working memory 208. CPU 200 compares (at S702) the model number and the software (and version) installed on the sequencing instrument with model number and approved software 324 to determine whether the model and software (for the sequencing instrument) are approved. If either the model number or the software are not approved, at S710, the created diagnostic analysis report is retained on server 30 and access to the report is prevented (it is not visible in the web-based UI). The diagnostic analysis reports that are retained are marked with a status of "retained" in the working memory 208. When the server 30 receives a request for the web-based UI, the server 30 does not retrieve any reports marked as "retained." In another aspect of the present disclosure, the complete run report may also be retained on the server, and access to the report is prevented.
[0129] If both the model number and software are approved ("Yes" at S702), the CPU 200 determines at S704 whether the sequencing instrument that generated the report has been qualified. The CPU searches the sequencing instrument report 318 (for the sequencing run) for the sequencing instrument identifier and retrieves (at 310) the status stored in the working memory 208. If the status is unqualified, or expired qualification, or untested ("No" at S704), the generated diagnostic analysis report is retained on the server 30 and access to the report is prevented at S710. Again, in one aspect of the disclosure, the complete run report may also be retained on the server and access to the file is prevented.
[0130] If the status for the sequencing instrument that created the sequencing instrument report 318 is qualified ("Yes" at S704), the CPU 200 determines if the reagents used in the sequencing run are qualified at S706. The CPU examines the sequencing instrument report 318 (for the sequencing run), looks up the identifier of the reagent, and retrieves its status. If the status is unqualified or untested ("No" at S706), the diagnostic analysis report that was created is retained on the server 30 and access to the report is prevented at S710. Again, in one aspect of the disclosure, the complete run report may also be retained on the server, and access to the file is prevented.
[0131] If the status for the reagent is qualified ("Yes" at S706), access to the generated diagnostic analysis report and complete run record is granted at S708. In one embodiment of the disclosure, CPU 200 notes the qualification for the sequencing instrument and reagents at the time the sequencing run is started. Thus, CPU 200 retrieves the start time from the sequencing instrument report and compares this time with the qualification date and time for both the reagent and the sequencing instrument. Thus, it may be the case that the sequencing instrument and reagents are qualified but after the start of the sequencing run. In this embodiment of the disclosure, the diagnostic analysis report may also be retained. Also, in other embodiments of the disclosure, the complete run report may also be retained.
[0132] In one embodiment of the present disclosure, the CPU 200 updates at least the case history 328 with the status of the available reports. In one embodiment of the present disclosure, an identifier for the storage location may be included. In one embodiment of the present disclosure, if the user is still logged into the system 1, the web-based UI is updated with the status change for the created report. In one embodiment of the present disclosure, if the user is logged out of the system 1, a subsequent login may result in an update of the web-based UI. In another embodiment of the present disclosure, a pop-up window may be displayed.
[0133] If the diagnostic analysis report or complete run record is retained, a notification of the status is displayed at S712. In one embodiment of the present disclosure, if the user is still logged into system 1, the web-based UI is updated with the status change to the diagnostic analysis report. In one embodiment of the present disclosure, the word retained may be displayed in a pre-set color, for example, red. In one embodiment of the present disclosure, if the user logs out of system 1, a subsequent login may result in an update of the web-based UI indicating that the diagnostic analysis report or complete run record is retained. In another embodiment of the present disclosure, a pop-up window may be displayed.
[0134] A run may be designed as a qualification run as described above and may also be designated for analysis by creating an analysis plan 316. In this case, the qualification analysis may be performed first. If the reagents and / or sequencing equipment have been qualified based on the qualification run, then the analysis may be performed as described as the analysis plan 316. For example, after S618, CPU 200 determines in S512 whether the qualification run is also a sample run, and, for example, an analysis plan is created.
[0135] If an analysis plan has not been created, e.g., it is determined that this is only a qualification run, then analysis of the sequencing run ends at S520, otherwise analysis proceeds to S514.
[0136] Once the sequencing instrument 10 or reagents have been qualified (or even if the reagents have not been qualified), the server 30 continues to monitor the status. For example, in S800, the CPU 200 monitors the expiration date of each registered reagent (reagent 312) stored in working memory. In S802, the CPU 200 determines whether any reagents have expired. If the reagents have expired ("Yes" in S802), the CPU 200 executes S622 to S626, which have been described above and will not be described again.
[0137] If none of the reagents have expired ("NO" in S802), the CPU 200 determines whether the current date has reached the warning date or notification date for the sequencing device based on the monitoring in S800 (S804). If the current date is equal to the warning date ("YES" in S806), the CPU 200 displays a notification in the web-based UI in S808. In one embodiment of the present disclosure, the notification may be a pop-up window. If the current date is after the warning date ("AFTER" in S806), the CPU 200 proceeds to S810 and determines whether the qualification period of any of the sequencing devices has expired. The CPU 200 monitors the qualification period for each sequencing device 10 registered in the working memory 208. This determination is based on the current date and the expiration date (if qualified) for the qualification period stored in the record of each sequencing device.
[0138] If the qualification period of the sequencing device has expired ("Yes" in S810), the CPU 200 changes the status for the sequencing device from Qualified to Qualification Expired in S812. The CPU 200 updates the status in the working memory 208 (if 312). In S814, the CPU 200 causes a notification to be displayed on the client terminal 10. For example, the CPU 200 may cause the web-based UI to display a pop-up window indicating that the qualification period has expired and prompt the user to qualify the sequencing device. In one embodiment of the present disclosure, the pop-up window may have a confirm button. Additionally, in an embodiment of the present disclosure, the web-based UI for the sequencing device will include the updated status. The updated status may be a particular color (e.g., red).
[0139] If the current date is before any warning date, the CPU 200 proceeds to S800.
[0140] In accordance with one embodiment of the present disclosure, if the software or software version installed on the sequencing instrument is updated, the sequencing instrument is declared disqualified. In one embodiment of the present disclosure, an administrator may log into the system 1 and through a web-based UI may indicate that new software or a new version of software has been installed on the sequencing instrument. The indication will identify the sequencing instrument. In response to receiving through the network interface 210, the CPU 200 updates the status for the sequencing instrument in the working memory (in 310) to disqualified if it was previously qualified. In one embodiment of the present disclosure, the CPU 200 may cause the web-based UI to have a confirmation screen or box to confirm the update (as the update may affect the status of the diagnostic analysis report). For example, the confirmation screen may indicate that "this action will disqualify the sequencer" (sequencing instrument) and that the sequencing instrument may remain disqualified until a qualification run is successfully performed. Other terms may be used and the terminology is not limited to the terms set forth herein.
[0141] CPU 200 may then cause a notification to be displayed at client terminal 10. For example, CPU 200 may cause the web-based UI to display a pop-up window indicating that the sequencing device has been disqualified and prompting the user to qualify the sequencing device. In one embodiment of the present disclosure, the pop-up window may have a confirm button. Additionally, in an embodiment of the present disclosure, the web-based UI for the sequencing device will include the updated status. The updated status may be a particular color (e.g., red).
[0142] According to aspects of the present disclosure, in addition to software and version information being entered for a sequencing device as described in the previous two paragraphs, hardware updates may be entered with the same results in status, for example, the status for a sequencing device may be set to unqualified if it was previously qualified.
[0143] Consistent with an embodiment of the present disclosure, an administrator may log into the system 1 (using a user ID and a passcode) to publish a retained diagnostic analysis report. In one embodiment of the present disclosure, a troubleshooting procedure will be completed before publishing a retained diagnostic analysis report. In one embodiment of the present disclosure, the administrator's web-based UI may include a list of retained diagnostic analysis reports along with a corresponding selection tool. For example, the selection tool may be a button or a checkbox. When the administrator uses the tool to indicate that a diagnostic analysis report will be published, the instruction is received by the server 30 through the network interface 210. In one embodiment of the present disclosure, the CPU 200 may cause the web-based UI to display a window that prompts the administrator to re-enter the passcode. The CPU 200 makes the report published by the administrator available for access by the web-based UI. For example, the CPU 200 updates the run history 314. The updated run history is used to generate the web-based UI. In another embodiment of the present disclosure, a pop-up window may be displayed indicating that a new diagnostic analysis report is available.
[0144] In one embodiment of the present disclosure, there may be a situation where an administrator changes a sequencing run from a qualification run, which affects the retention of diagnostic analysis reports. For example, changing the qualification run may cause the retained diagnostic analysis reports to be made public if the sequencing run has failed qualification and / or if any of the sequencing instruments and / or reagents used are currently qualified. In this case, in one embodiment of the present disclosure, the CPU 200 may cause a pop-up window to appear in the web-based UI to confirm the change of the qualification run with a selection tool such as a confirm button or a cancel button. The pop-up window may also include a feature such as "As a result of this action, currently retained reports will be made public."
[0145] In one aspect of the present disclosure, if the reagents used in the retained diagnostic analysis report have been qualified (after not being disqualified), the diagnostic analysis report is made public.
[0146] In one embodiment of the present disclosure, quality metrics may be stored for purposes of tracking and trending the performance of the sequencing instrument 10 and reagents over time. In this scenario, quality metrics may be captured for either diagnostic or research sequencing runs to which qualification materials 326 have been added. These data may be trended to identify quality that degrades over time but may still pass. If the system 1 detects a trend in declining quality, the user will be notified through a web-based UI that the sequencing instrument 10 and / or reagents may be compromised. The user may then be able to select a different sequencing instrument or reagent lot for the next diagnostic or research run. Alternatively, the user may be able to perform a full qualification run on the instrument 10 or reagent lot to confirm performance before proceeding.
[0147] In another aspect of the present disclosure, a central display may be located in a laboratory where multiple sequencing instruments 10 are located. The central display may display a dashboard showing all sequencing instruments and their corresponding statuses, and reagents and their corresponding statuses (including expiration dates). Each status may be displayed in a specific color as described above. In this aspect of the present disclosure, the central display may include a wireless communication interface configured to communicate with the server 30. If a status is changed for a sequencing instrument 10 or a reagent, the server 30 may send the changed status to the central display, which will display the updated status.
[0148] In another aspect of the present disclosure, each sequencing device may have a corresponding notification device located near the sequencing device. The notification device may be a light indicator or a display panel. When the notification device is installed by an authorized installer, the notification device is associated and registered with the sequencing device. The server 30 in the working memory 208 will add a network address for the notification device. In another aspect of the present disclosure, the notification device may be paired with the server 30. Once registered, the server may communicate any status information about the associated sequencing device to the notification device for display. For example, if the sequencing device is not disqualified, the light indicator may emit a red light, and if the sequencing device is qualified, the light indicator may emit a green light.
[0149] The colors described herein are examples and other colors may be used in the described indications.
[0150] Various aspects of the present disclosure may be embodied as a program, software, or computer instructions embodied or stored on a computer or machine usable or readable medium, or a collection of media that, when executed on a computer, processor, and / or machine, causes the computer or machine to perform the steps of a method. Machine-readable program storage devices, e.g., computer readable media, that tangibly embody a program of machine-executable instructions to perform various functionality and methods described in the present disclosure are also provided, e.g., computer program products.
[0151] The computer readable medium may be a computer readable storage device or a computer readable signal medium. The computer readable storage device may be, for example, a magnetic, optical, electronic, electromagnetic, infrared, or semiconductor system, apparatus, or device, or any suitable combination of the foregoing, but the computer readable storage device is not limited to these examples, except that the computer readable storage device does not include a computer readable signal medium. Further examples of the computer readable storage device may include, but are not limited to these examples, a portable computer diskette, a hard disk, a magnetic storage device, a portable compact disk read-only memory (CD-ROM), a random access memory (RAM), a read-only memory (ROM), an erasable programmable read-only memory (EPROM or flash memory), an optical storage device, or any suitable combination of the foregoing. Any tangible medium that may contain or store a program for use by or in connection with an instruction execution system, apparatus, or device may be a computer readable storage device.
[0152] A computer-readable signal medium may include a propagated data signal having computer-readable program code embodied therein, such as, but not limited to, in baseband or as part of a carrier wave. The propagated signal may take any of a number of forms, including, but not limited to, electromagnetic, optical, or any suitable combination thereof. A computer-readable signal medium may be any computer-readable medium (excluding computer-readable storage devices) that can communicate, propagate, or transport a program for use by or in connection with a system, apparatus, or device. The program code embodied on the computer-readable signal medium may be transmitted using any suitable medium, including, but not limited to, wireless, wired, fiber optic cable, RF, etc., or any suitable combination of the foregoing.
[0153] The terminology used herein is for the purpose of describing particular embodiments only, and is not intended to limit the scope of the disclosure, nor is it intended to be a limiting recitation. Many modifications and variations will be apparent to those skilled in the art without departing from the scope and spirit of the disclosure.
[0154] Although the invention has been described with reference to the above examples, it will be understood that modifications and variations are encompassed within the spirit and scope of the invention. Accordingly, the invention is limited only by the scope of the following claims.
Claims
1. 1. A system comprising: a memory configured to store (i) an identifier of a sequencing instrument and an associated status including qualified or disqualified, (ii) an identifier of a reagent and an associated status including qualified and disqualified, and (iii) an identifier of approved software for one of the sequencing instruments; a network interface configured to communicate with the sequencing device and a client terminal; and 1. A processor comprising: receiving a report from the sequencing device via the network interface about the sequencing run, the report including an identifier of the sequencing device that generated the report, an identifier of reagents used in the sequencing run, an identifier of software installed on the sequencing device, and a result of the sequencing run; Determining whether the sequencing run has been designated as a qualification run It is structured as follows: If it is determined that the sequencing run is designated as the qualification run, determining whether the software installed on the sequencing device is approved software by comparing an identifier of the software in the report with an identifier in the memory, and if the software installed on the sequencing device is not approved, then the associated status for the sequencing device or the reagent is disqualified; Inspecting the results of the sequencing run to determine whether the sequencing instrument or the reagents have been qualified; updating an associated status for at least one of the sequencing instrument and the reagent in response to the survey; The processor is further configured to:
2. 2. The system of claim 1, wherein the processor is further configured to receive from the client terminal through the network interface a designation of the sequencing run as the qualification run, the designation including whether the qualification run performs qualification of the sequencing instrument, the reagents, or both the sequencing instrument and the reagents.
3. 3. The system of claim 2, wherein the processor is further configured to send a notification to the client terminal through the network interface indicating whether the sequencing instrument or the reagent has been qualified based on the qualification run.
4. the processor is further configured to determine whether the requested analysis is in a diagnostic mode; If the analysis is determined to be in a diagnostic mode, the processor further determining whether the software installed on the sequencing device is approved software by comparing an identifier of the software in the report with the identifier in the memory; determining whether the sequencing device has been qualified based on the associated status stored in the memory for the sequencing device identified in the report; and determining whether the reagents used in the sequencing run were qualified based on the associated status stored in the memory for the reagents identified in the report; It is structured as follows: the processor is configured to retain in the memory a diagnostic analysis report generated from the report if the software installed on the sequencing device is not approved or if the sequencing device and / or the reagents are not qualified. The system of claim 1 .
5. 5. The system of claim 4, wherein the processor is configured to allow the client terminal to access the diagnostic analysis report if the software installed on the sequencing device is approved and both the sequencing device and the reagents have been qualified, and allowing the access enables the diagnostic analysis report to be displayed by a user interface of the client terminal.
6. 5. The system of claim 4, wherein an expiration date of each of the reagents is stored in association with an identifier of the reagent, and the processor is further configured to change the status of the reagent to disqualified if the current date is after the expiration date of the reagent.
7. 5. The system of claim 4, wherein the processor is further configured to send a notification to the client terminal through the network interface that the diagnostic analysis report has been retained.
8. 5. The system of claim 4, wherein the processor is further configured to send a notification to the client terminal through the network interface that the software installed on the sequencing device is not approved or that at least one of the sequencing device and the reagents have not been qualified.
9. 5. The system of claim 4, wherein the processor is further configured to disable generation of an analysis plan in the diagnostic mode if the software installed on the sequencing device is not approved or if the sequencing device is not qualified.
10. The system of claim 4 , wherein the processor is further configured to receive, via the network interface, instructions to release the retained diagnostic analysis report, the instructions including an authentication passcode.
11. 2. The system of claim 1, further comprising a user interface, the user interface displayable on the client terminal, the user interface configured to display available sequencing instruments, the available sequencing instruments including qualified and disqualified sequencing instruments, and the user interface having a selection window allowing selection of the sequencing instrument and allowing selection of the sequencing run as the qualification run.
12. 12. The system of claim 11, wherein the user interface is accessible through a web browser on the client terminal, and the processor authorizes access to the user interface.
13. The system of claim 12 , wherein the user interface displays a qualification status of each of the sequencing instruments.
14. 2. The system of claim 1, wherein the associated status for the sequencing device further includes expired qualification, and when the sequencing device is determined to be qualified, a qualification date is stored in the memory in association with an identifier of the qualified sequencing device, and the sequencing device remains qualified for a period of time serving as a qualification period, and the processor is further configured to determine when the period of time expires, and when the period of time is determined to have expired, the processor is configured to change the associated status for the sequencing device to expired qualification.
15. 15. The system of claim 14, wherein the processor is further configured to send a notification to the client terminal through the network interface that the qualification period is about to expire, the sending occurring at a time before the period expires, the notification being configured to cause a prompt to be displayed on a user interface displayable on the client terminal, the prompt indicating that a run of the sequencing device should be performed as the qualification run to perform qualification of the sequencing device.
16. 15. The system of claim 14, wherein the processor is further configured to receive, through the network interface, settings of the time period and the time before the time period expires, the settings including an authentication passcode.
17. 12. The system of claim 11, wherein the processor is further configured to receive information regarding a hardware update of the sequencing equipment, the information being entered into the user interface of the client terminal and communicated through the network interface, and the processor is configured to change an associated status of the sequencing equipment to disqualified in response to receiving the information.
18. 18. The system of claim 17, wherein the processor is configured to send a notification to the client terminal through the network interface when an associated status of the sequencing device changes, the notification being configured to cause a prompt to be displayed on the user interface, the prompt indicating that the sequencing device should be run as a qualification run to perform qualification of the sequencing device.
19. 2. The system of claim 1, wherein the processor is further configured to determine whether the requested analysis is in research mode, and if the analysis is determined to be in research mode, the processor is configured to allow access by the client terminal to a research analysis report created by the processor from the report, and wherein allowing the access enables display of the research analysis report by a user interface of the client terminal even if the sequencing instrument is not qualified or the reagents used are not qualified.
20. 2. The system of claim 1, wherein the memory further includes an identifier of a qualification material, the report further includes an identifier of the qualification material used to generate the report, and the processor is configured to determine that the sequencing instrument is not qualified if the identifier of the qualification material used to generate the report does not match the identifier of the qualification material stored in the memory.
21. 1. A system comprising: a memory configured to store (i) an identifier of a diagnostic device and an associated status including qualified or disqualified, (ii) an identifier of a reagent and an associated status including qualified and disqualified, and (iii) an identifier of approved software for one of the diagnostic devices; a network interface configured to communicate with the diagnostic device and a client terminal; and 1. A processor comprising: receiving a report from the diagnostic device via the network interface for a test parameter, the report including an identifier of the diagnostic device that generated the report, an identifier of a reagent used for the test parameter, an identifier of software installed on the diagnostic device, and a result for the test parameter; Determine if the test parameters are designated as a qualification run It is structured as follows: If it is determined that the test parameters are designated for the qualification run, determining whether the software installed on the diagnostic device is approved software by comparing an identifier of the software in the report with an identifier in the memory, where if the software installed on the diagnostic device is not approved, then the associated status for the diagnostic device or the reagent is disqualified; examining the results of the test parameters to determine whether the diagnostic device or the reagent is qualified; updating an associated status for at least one of said diagnostic device and said reagent in response to said survey; The processor is further configured to:
Citation Information
Patent Citations
Nucleic acid sequencing system and method
CN101652780A
Remote medical diagnosis system and method
JP2010525363A
Analysis system and procedures
US20060265133A1
Environment and Method for Rapid Analysis of Genomic Sequence Data
US20140032125A1
Method and apparatus for generating objective medical second opinion
US20150106117A1
